Continual Communication for Happy Clients and Colleagues
If you want to keep your clients, bosses, and colleagues happy, plenty of updates, can really help.
More needs to be done to help the NHS with their sustainability targets
This year’s theme at ReMed was ‘Beyond Disposable: Building a Circular Economy for Medical Devices’ and had a focus on interdisciplinary collaboration. The common theme throughout the conference was the recognition and drive to take practical, immediate actions towards a more circular econom
English councils face £9.3 billion deficit by 2026-27
Councils in England face a £9.3 billion funding shortfall by 2026-27, according to a new report from the Bennett Institute for Public Policy, Cambridge, and Newcastle University’s Centre for Urban and Regional Development Studies.
Celebrating 25 years of building on the web
Cambridge digital agency Studio 24 turns 25.
Lily Arkwright revolutionises Black Friday 2024 with Ethical Luxury and Global Impact
Manchester, UK – October 2024 – This Black Friday, Lily Arkwright is redefining the shopping experience by prioritising transparency, sustainability, and social responsibility.
International award for ‘Connie the Puppet’ reveals an appetite for change in ethics and compliance
The award-winning project takes an innovative approach to ethics and compliance – making it tangible, accessible, engaging – and most importantly – actionable for all employees.
New partnership with Prepared With Love
It Takes a City (Cambridge) announces a new partnership with Cambridge Dining Co who provides delicious meals for rough sleepers at Crossways emergency night shelter.
Stevenage Bioscience Catalyst scoops the Most Successful Science Park (Small) Award at UKSPA40 Anniversary Awards
Congratulations to everyone who took part and for a fantastic and insightful conference from UKSPA, The United Kingdom Science Park Association. Dr Sally Ann Forsyth OBE, CEO of SBC, said: “Stevenage Bioscience Catalyst is truly honoured to win Most Successful Science Park (Small) Award, and for the SBC graduate Autolus Therapeutics to have won Most Successful Company, nominated by SBC as an…
Cambridge reveals innovation blueprint to become world’s leading science and tech region
With the aim to achieve the same level of innovation in the next 10 years as the last 25 years.
AI to help engage communities through Greater Cambridge Shared Planning partnership with the University of Liverpool
This is a joint release on behalf of Cambridge City Council, South Cambridgeshire District Council and the Greater Cambridge Shared Planning Service.
Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for fibrotic and fibro-inflammatory indications
CAL101 is an anti-S100A4 monoclonal antibody (mAb) and Calluna’s lead drug candidate Study demonstrated a favorable safety, pharmacokinetic (PK) and immunogenicity profile CAL101 is now entering Phase 2 clinical development
Cambridge Index falls 2.1%
The Cambridge Index declined 410.9 points or 2.1% to close at 19,508.6, as six out of the top ten index heavyweights posted weekly losses in their share price.
Cambridge-based Alchemie Technology receives recognition for sustainability in the textile industry
Cambridge: Monday 21st October 2024: Leading clean-tech company Alchemie Technology was featured in a prestigious new book marking the 75th anniversary of the Commonwealth and King Charl
Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS
Innovative research institute streamlines operations and enhances collaboration with unified laboratory informatics platformBaltimore, MD, 22 October 2024 – Sapio Sciences, the science-aware™ lab informa
New blog: What are the benefits of digital pathology?
Digital pathology is used within pathology, computer science and image analysis and is transforming how pathologists diagnose and research diseases. Within this article, we will conduct a deep dive into the benefits of digital pathology.
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Surflex-Dock structure-based design method outperforms other molecular docking methods for predicting non-cognate ligand pose of macrocyclic compounds Results published Open Access in Journal of Computer-Aided Molecular Design
Cognidox unveils exciting new integration features in v10.4 release
Cognidox, a leading provider of document management solutions for the high-tech, medical device, and life sciences industries, has unveiled the latest innovations in their v10.4 platform release.
Award highlights from Costello Medical Consulting
Award winning commitment.
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK).
The first five: Marshall USA selects crew chiefs for Greensboro facility
Marshall’s new facility in Greensboro, North Carolina, has taken a major step forward with the recruitment of a first team of five highly qualified maintenance crew chiefs.
Overcoming pharmaceutical and other materials issues before they exist
Two new scientific papers on the conclusions of the 7th Crystal Structure Prediction Blind Test.
Lily Lin visits Gluetacs Therapeutics
On 15th October 2024, Lily Lin, CEO of Excellence First Enterprise Consultancy, accompanied by Iris Li and Yang Qing from the Lingang Cambridge Network (LCN), visited Gluetacs Therapeutics, a pioneering biotech company and LCN member. Dr. Yang, the founder of Gluetacs, along with his colleagues, warmly welcomed Lily and provided updates on their recent North American business expansion.
Connect and collaborate at a free business workspace in South Cambridgeshire
Regional businesses, entrepreneurs, community groups and charities are being invited to Cambourne to try a new collaborative working space - free of charge until the new year!
Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.
The economic cost of living with a rare disease across Europe
Although rare diseases affect a relatively small number of patients, collectively there are an estimated 30 million people in Europe living with 6,000-7,000 known rare diseases (RDs).